Product Information
BUTRANS 10 MCG/HR PATCH is a brand product labeled by Purdue Pharma LP, priced at $73.6002 per EA under NDC 59011075104. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 30, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 ug/h
Manufacturer
Purdue Pharma LPNDC
59011075104
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
BUPRENORPHINEApproval Type
New Drug (NDA)
FDA Application
NDA021306FDA Approved
6/30/2010
TE Code
AB
On Market Since
2/14/2011
Pharmacological Classes
Price Statistics
The NADAC for BUTRANS 10 MCG/HR PATCH has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 35.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $73.6002 per EA |
|---|---|
| All-time high | $129.0945 (Oct 11, 2023) |
| All-time low | $54.1876 (Nov 28, 2013) |
| 52-week high | $73.7740 |
| 52-week low | $73.6002 |
| Median price | $88.3793 |
| Average price | $92.3286 |
| Largest weekly change | -42.5% (Jan 3, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Purdue Pharma LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
buprenorphine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Partial Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUTRANS 10 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUTRANS 10 MCG/HR PATCH, manufactured by Purdue Pharma LP, is $73.6002 per EA (NDC 59011075104), effective Sep 30, 2026.
How has the price of BUTRANS 10 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUTRANS 10 MCG/HR PATCH has risen 35.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUTRANS 10 MCG/HR PATCH?
Since Nov 28, 2013, the NADAC for BUTRANS 10 MCG/HR PATCH has ranged from a low of $54.1876 (Nov 28, 2013) to a high of $129.0945 (Oct 11, 2023), with a median of $88.3793 per EA.
Are there cheaper alternatives to BUTRANS 10 MCG/HR PATCH?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPRENORPHINE 10 MCG/HR PATCH, is $30.1705 per EA — about 59% below BUTRANS 10 MCG/HR PATCH.
Who manufactures BUTRANS 10 MCG/HR PATCH?
BUTRANS 10 MCG/HR PATCH (NDC 59011075104) is labeled by Purdue Pharma LP, and CMS classifies it as a brand product.